MAIA Biotechnology | Investor Presentation Deck | 31 slides · page 22 of 31
The slide outlines a clinical trial process flow involving SCLC and NSCLC patient baskets, immune activation, and subsequent combination therapies leading to a Phase 3 expansion.
Pitch deck · roadmap · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 source-note 1/1 subtitle 1/1 title 1/1
Components 4
process source-note subtitle headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1